Thu Jan 12, 2023 – 7:42 pm EST
(LifeSiteNews) — The U.S. government and in particular the Department of Defense (DOD) fully sponsored and controlled the COVID-19 gene-based vaccine program from the start, avoiding nearly all regulations applicable to medical and pharmaceutical products while orchestrating a deceptive public relations campaign to convince the population that customary testing and production safeguards were firmly in place.
According to an analysis of documents obtained through the Freedom of Information Act (FOIA), conducted by retired pharmaceutical industry executive Alexandra Latypova, the DOD utilized multiple legal maneuvers to establish injectables that avoided nearly all applicable regulations while ensuring the process of their production and their contents would be untraceable.
In an email correspondence with LifeSiteNews, Latypova explained that when President Donald Trump declared a Public Health Emergency (PHE) under the authority of the Stafford Act, this meant that “medical countermeasures” would not be “regulated or safeguarded as normal pharmaceutical products (21 USC 360bbb-3(k).”
As LifeSite has previously reported, the DOD was chief operating officer of the entire project, which means they directed, managed, and oversaw the development, manufacture and distribution of all COVID-related countermeasures utilizing an established network of military contractors.
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors